You are here:
The Department of Consumer and Business Services (DCBS) adopted final rules implementing the 2018 Prescription Drug Price Transparency Act to provide notice and disclosure of information relating to the cost and pricing of prescription drugs in order to provide accountability for prescription drug pricing. The rule was adopted February 25, 2019, and became effective March 1, 2019.
Jesse Ellis O'Brien Senior Policy Analyst Oregon Division of Financial Regulation 971-707-3670Jesse.E.Obrien@oregon.gov
Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how